Latest Breaking News On - Ingrid delaet - Page 3 : comparemela.com

Neurocrine Biosciences, Inc (NASDAQ:NBIX) Shares Bought by M&G Investment Management Ltd

Neurocrine Biosciences, Inc (NASDAQ:NBIX) Shares Bought by M&G Investment Management Ltd
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United statesNeurocrine biosciencesIngrid delaetDimensional fund advisorsHoldings channelMg investment management ltdIeq capitalNeedham companyNeurocrine biosciences incEnvestnet portfolio solutions incG investment management ltdJpmorgan chase coWestpac banking corpPrincipal financial group incCanaccord genuity groupFree report

M&G Investment Management Ltd Acquires 5,781 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)

M&G Investment Management Ltd Acquires 5,781 Shares of Neurocrine Biosciences, Inc (NASDAQ:NBIX)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Los angelesUnited statesIngrid delaetNeurocrine biosciencesG investment management ltdJacobs levy equity management incMg investment management ltdNeurocrine biosciences incCharles schwab investment management incLos angeles capital managementCapital partnersFree reportAngeles capital managementLevy equity managementCharles schwab investment managementSchwab investment management

Brokers Set Expectations for Neurocrine Biosciences, Inc s FY2025 Earnings (NASDAQ:NBIX)

Brokers Set Expectations for Neurocrine Biosciences, Inc s FY2025 Earnings (NASDAQ:NBIX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesLos angelesEric benevichNeurocrine biosciencesLeerink partnrsNeurocrine bioscienceIngrid delaetWells fargo companyNeurocrine biosciences company profileNeurocrine biosciences incLos angeles capital managementNorges bankWestfield capital management coSecurities exchange commissionFree reportGet free report

Citigroup Raises Neurocrine Biosciences (NASDAQ:NBIX) Price Target to $150 00

Neurocrine Biosciences (NASDAQ:NBIX – Free Report) had its target price increased by Citigroup from $140.00 to $150.00 in a research report released on Friday, Benzinga reports. The firm currently has a neutral rating on the stock. Other analysts also recently issued research reports about the company. Oppenheimer raised their price objective on Neurocrine Biosciences from […]

Los angelesUnited statesNeurocrine biosciencesDavidw boyerIngrid delaetNeedham companyCantor fitzgeraldVanguard group incNeurocrine biosciences incCapital partnersJpmorgan chase coLos angeles capital managementNeurocrine biosciences company profileBrown advisory incSecurities exchange commissionFree report

Neurocrine Biosciences (NASDAQ:NBIX) PT Raised to $216 00 at Oppenheimer

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) had its price objective lifted by research analysts at Oppenheimer from $200.00 to $216.00 in a research report issued on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price would suggest a potential upside of 53.51% from the stock’s previous close. […]

New yorkUnited statesNeurocrine biosciencesIngrid delaetEric benevichNeurocrine biosciences company profileGoldman sachs groupCantor fitzgeraldSecurities exchange commissionFintrust capital advisorsNeurocrine biosciences incBluepath capital managementWells fargo companyAsset management one coGet free reportExchange commission